Pfizer plots euro-sterling bond sale

Pfizer plans to sell a benchmark-sized four-part bond denominated in euros and sterling, one of the banks managing the sale said. Proceeds from the sale of the bonds, which will consist of four-year, seven-year and 12-year euro-denominated tranches and a 29-year sterling-denominated bond, will help fund its $68 billion takeover of Wyeth. Report


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.